Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE
06 mai 2022 06h46 HE
|
Hofseth Biocare ASA
Roger Hofseth has today, 6 May 2022, bought 45,000 shares at an average price of NOK 3.7764 per share. Roger Hofseth is CEO and primary insider of Hofseth BioCare ASA. After the transaction, Mr....
Hofseth Biocare ASA: FIRST QUARTER 2022 FINANCIAL REPORT
06 mai 2022 02h00 HE
|
Hofseth Biocare ASA
HBC had gross operating revenues of NOK 30.8m (16.8m) in the first quarter 2022. Cost of sales (CoGS) amounted to NOK 22.1m (8.4m) in the quarter. Operating profit (EBITDA) was NOK -26.2m (-18.8m) and...
Hofseth Biocare ASA: APPROVAL OF NEW SHARE INCENTIVE PROGRAM FOR CONSULTANTS – MANDATORY NOTIFICATION OF TRADE
29 avr. 2022 09h24 HE
|
Hofseth Biocare ASA
Reference is made to the decision by the annual general meeting of Hofseth BioCare ASA ("HBC" or the "Company") today, 29 April 2022, to carry out a private placement towards Brilliant Invest 2 AG...
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING
29 avr. 2022 09h17 HE
|
Hofseth Biocare ASA
The AGM in Hofseth BioCare ASA was held in Kipervikgata 13, Ålesund today on Friday 29 April 2022.All matters were decided according to the proposals in the notice.Please find the minutes from the AGM...
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2022
08 avr. 2022 09h49 HE
|
Hofseth Biocare ASA
The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Kipervikgata 13, 6003 Ålesund, on 29 April 2022 at 13:00 CET. Please find the notice to the Annual General...
Hofseth Biocare ASA: HBC ANNUAL REPORT 2021
25 mars 2022 11h48 HE
|
Hofseth Biocare ASA
Today, 25 March 2022, the Board of Directors of Hofseth BioCare ASA approved the Annual Report for 2021. Please find the Annual Report 2021 and ESG Report attached. For further information, please...
Hofseth Biocare ASA: HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE
11 mars 2022 02h00 HE
|
Hofseth Biocare ASA
Hofseth BioCare (HBC) has been named Best Sustainable Biotech Company 2022 in the Global Health & Pharma Biotechnology Awards. The award is in recognition of HBC’s 15 years of pioneering research...
Hofseth Biocare ASA: HOFSETH BIOCARE SECURES INNOVATION AWARD FOR MEDICAL NUTRITION
08 févr. 2022 02h00 HE
|
Hofseth Biocare ASA
Hofseth BioCare (HBC) has been named Most Innovative Human Medical Nutrition Ingredients Producer in the ghp Technology Awards announced today. The award recognises the 15 years’ R&D and...
Hofseth Biocare ASA: FOURTH QUARTER 2021 FINANCIAL REPORT
04 févr. 2022 01h59 HE
|
Hofseth Biocare ASA
Hofseth BioCare ASA (“HBC”) had gross operating revenues of NOK 26.1m (23.1m) in the fourth quarter and total operating revenues of NOK 87.6m (69.3) for the full year. Cost of sales (CoGS) amounted to...
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE
22 déc. 2021 08h34 HE
|
Hofseth Biocare ASA
Roger Hofseth has today, 22 December 2021, bought 50,000 shares at an average price of approx. NOK 7.332 per share. Roger Hofseth is CEO and primary insider of Hofseth BioCare ASA. After the...